Sign in

CIK 0001636651

  • Non-accelerated filer
  • Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465270895
Phone
+1 212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-22 Tardio Jason Chief Operating Officer Grant or award +28,125 28,125
2024-02-22 Tardio Jason Chief Operating Officer Grant or award · Stock Option (Right to Buy) +168,750 168,750
2023-02-23 Tardio Jason Chief Operating Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2022-09-12 Tardio Jason Chief Operating Officer Sale −17,344 $2.15 $37K 0
2022-04-08 Tardio Jason Chief Operating Officer Grant or award · Stock Option (Right to Buy) +87,498 87,498
2022-04-08 Tardio Jason Chief Operating Officer Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-02-03 Tardio Jason Chief Operating Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2021-07-01 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2021-02-05 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2020-12-17 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2020-11-25 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +44,000 44,000
2020-06-19 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2019-11-18 Tardio Jason Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 1 of 1 · 13 trades